Loading...

Anavaj Sakuntabhai

Home / Investigators  / Anavaj Sakuntabhai

Anavaj Sakuntabhai

Head, Functional Genetics of Infectious Diseases, Pasteur Institute

Email: anavaj@pasteur.fr
Phone: 33 1 44 38 91 03

28 Rue du Docteur Roux, 75015 Paris, France

Website

Dr. Anavaj Sakuntabhai is a researcher specializing in human genetics of infectious diseases. He received his MD from Chulalongkorn University in Bangkok, Thailand and completed post-doctoral training in Internal Medicine and Dermatology at the Ramathibodi Hospital, Mahidol University. He also has a MD from the University of Newcastle in Tyne, UK.  Finally, he earned his PhD in Human Molecular Genetics from the University of Oxford. He joined the Institut Pasteur in Paris in 2000 as a Senior Scientist and in 2007 became the leader of the Laboratory of Genetics of Human Response to Infections. In 2010 he created and became the head of the Functional Genetics of Infectious Diseases Unit.

The Functional Genetics of Infectious Diseases unit studies the basis of human genetic susceptibility to major human pathogens. They currently focus on mosquito-borne infections (malaria and dengue). They aim to identify genes governing infection outcome and transmissibility, within two important contexts: 1) That of the pathogen exploitation of the host and maximization of onward transmission; 2) The environmental context, placing emphasis upon the exogenous factors that impact upon the within-host dynamic of the pathogen and thus influence the outcome of infection.

Recent Publications

  • Saint-André, V, Charbit, B, Biton, A, Rouilly, V, Possémé, C, Bertrand, A et al.. Smoking changes adaptive immunity with persistent effects. Nature. 2024; :. doi: 10.1038/s41586-023-06968-8. PubMed PMID:38355791 .
  • Dott, T, Culina, S, Chemali, R, Mansour, CA, Dubois, F, Jagla, B et al.. Standardized high-dimensional spectral cytometry protocol and panels for whole blood immune phenotyping in clinical and translational studies. Cytometry A. 2024;105 (2):124-138. doi: 10.1002/cyto.a.24801. PubMed PMID:37751141 .
  • Tawfik, A, Kawaguchi, T, Takahashi, M, Setoh, K, Yamaguchi, I, Tabara, Y et al.. Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults. Expert Rev Vaccines. 2023;22 (1):826-838. doi: 10.1080/14760584.2023.2262563. PubMed PMID:37747798 .
  • COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621 (7977):E7-E26. doi: 10.1038/s41586-023-06355-3. PubMed PMID:37674002 PubMed Central PMC10482689.
  • Villain, E, Chanson, A, Mainka, M, Kampschulte, N, Le Faouder, P, Bertrand-Michel, J et al.. Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks. iScience. 2023;26 (8):107422. doi: 10.1016/j.isci.2023.107422. PubMed PMID:37575177 PubMed Central PMC10415927.
  • Ceruti, A, Dia, N, Bakarey, AS, Ssekitoleko, J, Andriamandimby, SF, Malwengo-Kasongo, P et al.. A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field. J Clin Virol. 2023;162 :105422. doi: 10.1016/j.jcv.2023.105422. PubMed PMID:36989731 PubMed Central PMC9981265.
  • Chauvin, C, Levillayer, L, Roumier, M, Nielly, H, Roth, C, Karnam, A et al.. Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants. iScience. 2023;26 (3):106124. doi: 10.1016/j.isci.2023.106124. PubMed PMID:36776936 PubMed Central PMC9894676.
  • Levillayer, L, Cassonnet, P, Declercq, M, Santos, MD, Lebreton, L, Danezi, K et al.. SKAP2 Modular Organization Differently Recognizes SRC Kinases Depending on Their Activation Status and Localization. Mol Cell Proteomics. 2023;22 (1):100451. doi: 10.1016/j.mcpro.2022.100451. PubMed PMID:36423812 PubMed Central PMC9792355.
  • Bergstedt, J, Azzou, SAK, Tsuo, K, Jaquaniello, A, Urrutia, A, Rotival, M et al.. The immune factors driving DNA methylation variation in human blood. Nat Commun. 2022;13 (1):5895. doi: 10.1038/s41467-022-33511-6. PubMed PMID:36202838 PubMed Central PMC9537159.
  • Posseme, C, Llibre, A, Charbit, B, Bondet, V, Rouilly, V, Saint-André, V et al.. Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation. Cell Rep. 2022;39 (13):110989. doi: 10.1016/j.celrep.2022.110989. PubMed PMID:35767946 PubMed Central PMC9237956.
Search PubMed